Cory, Melinda J.
Durand, Phillippe
Sillero, Rafael
Morin, Luc
Savani, Rashmin
Chalak, Lina
Angelis, Dimitrios http://orcid.org/0000-0002-1071-1960
Article History
Received: 5 December 2021
Revised: 21 March 2022
Accepted: 26 March 2022
First Online: 14 April 2022
Competing interests
: R. Savani is on the Scientific Advisory Council of Mallinckrodt Pharmaceuticals, which had no role in the development of this review. The other authors declare no competing interests.